Efficacy of recombinant human interferon α-2b on experimental endometriosis
Authors:
- Arif KokcuAKArif Kokcu
- 1 July 2008
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 139 (1) , 95-99
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Use of intraperitoneal interferon α-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trialFertility and Sterility, 2002
- Treating endometriosis as an autoimmune diseaseFertility and Sterility, 2001
- Immunobiology of endometriosisFertility and Sterility, 2001
- Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon- α-2b in a murine modelFertility and Sterility, 1999
- Endometriosis: abnormal endometrium and dysfunctional immune responseCurrent Opinion in Obstetrics and Gynecology, 1998
- IFN-α2b Suppresses the Fibrogenic Effects of Insulin-Like Growth Factor-1 in Dermal FibroblastsJournal of Interferon & Cytokine Research, 1998
- All-trans retinoic acid and interferon-?-2a in patients with metastatic or recurrent carcinoma of the uterine cervixCancer, 1997
- Pathogenesis of endometriosisThe Lancet, 1992
- Immunology and endometriosisFertility and Sterility, 1992
- Recombinant human leukocyte interferon‐α 2b stimulates the synthesis and release of a 90k tumor‐associated antigen in human breast cancer cellsInternational Journal of Cancer, 1988